YAFIT AZIZIAN: Open Payments
NPI 1245568062 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 84 payments from 16 companies in 2025. Trend: 2023 $1,217 · 2024 $1,406 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 31 | $371 |
| Galderma Laboratories, L.P. | 19 | $292 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| ABBVIE INC. | 5 | $110 |
| Janssen Biotech, Inc. | 6 | $104 |
| PFIZER INC. | 4 | $79 |
| Incyte Corporation | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Organon LLC | 2 | $43 |
| Amgen Inc. | 2 | $40 |
Products named: SOFDRA, DUPIXENT, TREMFYA, CIBINQO, SKYRIZI, OPZELURA, COSENTYX, OTEZLA.
Industry payments across NY — which companies pay providers there.
